Resources

Aaron, L. A. Burke, M. M., and Buchwald, D. (2000, January 24). Overlapping conditions amoung patients with chronic fatigue syndrome, fibromyalgia and temporomadibular disorder. Archives of Internal Medicine, 160(15), pp. 2398-2401.

Abeles, A.M., Pillinger, M.H., Solitar, B.M. et al. (2007). Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 146(10), pp. 726-734.

Amel Kashipaz, M. R., Swinden, D., Todd, I., Powell, R. J. (2003, May). Normal productin of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured clood mononuclear cells. Clinical Exp. Immunology, 132(2), pp. 360-365 Baliki, M.N., Geha, P.Y., Apkarian, A.V. (2007). Spontaneous pain and brain activity in neuropathic pain: functional MRI and pharmacologic functional MRI studies. Curr Pain Headache Rep 11(3), pp. 171-177.

Bennett, R. (1998, March). Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr. Opin. Rheumatology, 10(2), pp. 95-103.

Bennett, A. L., Chao, C. C., Hu, S., Buchwald, D. Fagioli, L. R., Schur, P. H., Peterson, P. K., & Komaroff, A. L. (1997, March). Elecation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. Journal of Clinical Immunology, 17(2), 160-166.Bradley, L. A., McKendree-Smith, N. L., and Alarcon, G. S. (2000). Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr. Rev. Pain, 4(2), pp. 148-57.

Berwaerts, J, Moorkens G. & Abs, R. (1998). Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Hormone IGF Research 8(Suppl. B) 127-129.

Brown, M.M., Jason LA. (2007, May 31). Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 6(1), p.6.

Buchwald, D. (1996, May). Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum. Dis. Clin. North America, 22(2), pp. 219-243.

Buskilia, D. (2001, March). Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr. Opin. Rheumatol., 13(2), pp. 117.127.

Buskila, D. and Press, J. (2001, December). Neuroendocrin mechanisms in fibromyalgia-chronic fatigue. Best. Pract. Res. Clin. Rheumatol., Isreal, 15(5), pp. 747-758.

Caligiuri, M., Murray, C., Buchwald, D., Levine, H., Cheney, P., Peterson, D., Komaroff, A. L., & Ritz, J. (1987, November). Phenotypic and functional deficiency of natural killer cells in patients with chornic fatigue syndrome. Journal of Immunology, 139(10), 3306-3313

Calis, M., Gokce, C., Ates, F., Ulker, S., Izgi, H. B., Demir, H., Kirnap, M., Sofuoglu, S., Durak, A. C., Tutus, A., and Kelestimur, F. (2004), January). Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J of Endocrinology Invest, 27(1), pp. 42-46.

Center for Disease Control and Prevention. www.cdc.gov

Cocchetto, A. (2003, Spring). The Ciguatera Epitope: So What Do We Really Know Thus Far? The National Forum, 6(4), pp. 1, 4-5.

Cook, D. B., Lange, G, Ciccone, D.S., Liu, W.C., Steffener, J., Natelson, B.H. (2004, February). Functional imaging of pain in patients with primary fibromyalgia. Journal of Rheumatology, 31(2), pp. 364-378.

Crofford, L. J. (1998). The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatology, 57, (Suppl.2), pp. 67-71.

Davies, C. (2004). The Trigger Point Therapy Workbook: Your self-treatment guide for pain. Oakland, CA: New Harbinger Publications, Inc.

Ferner, K.E. (Spring 2003). Mind-Body-Spirit, Treating the Whole Person. Paradigm, Vol. 7(1), pp. 8-9.

Gerwin, R. D. (2001, October). Classification, epidemiology, and natural history of myofascial pain syndrome. Current. Pain Headache Rep., 5(5), pp. 412-420.

Gerwin, R. (2007). Trigger points: a comprehensive hypothesis of trigger point formation. J Musculoskel Pain 15 (Supp 13):12 item 14.

Gremillion, R.B. (1996, April) Fiobromyalgia: Recognizing and Treating an Elusive Syndrome. The Physician and Sportsmedicine, 16(4), pp.55- 56).

Gustein-Good, M. (1940). Idiopathic myalgia simulating visceral and other diseases. Lancet, 2, pp. 326-328.

Hong, C. Z. (2002, November). New Trends in myofascial pain syndrome. Zhonghua Yi Xue Za Zhi (Taipei), 65(11), pp. 501.512.

Jason, L. A., Taylor, R. R. and Kennedy, C. L. (2000, September-October). Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosomatic Medicine, 62(5), pp. 655.663.

Konstantinov, K., von Mikecz, A., Buchwald, D., Jones, J. Gerace, L., and Tan, E. M. (1996, October). Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. Journal of Clinical Investigation, 15:98(8), 1888-1896.

Macedo, J.A., Hesse, J., Turner, J.D., Ammerlaan, W., Gierens, A., Hellhammer, D.H., Muller, C.P. (2007, Aug). Adhesion molecules and cytokine expression in fibromyalgia patients: increased L-selectin on monocytes and neutrophils. J Neuroimmunol., 188(1-2), pp. 159-166.

Moorkens, G. Berwaerts, J. Wyanants, H, & Abs, R. (2000, July). Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clinical Endocrinology (Oxf) 53(1), 99-106.

Naschit,z J.E., Slobodin, G., Sharif, D., Fields, M., Isseroff, H., Sabo, E., Rosner, I. (2008, May). Electrocardiographic QT interval and cardiovascular reactivity in fibromyalgia differ from chronic fatigue syndrome. Journal: Eur J Intern Med.,19(3), pp. 187-191.

National Institute of Arthritis and Musculoskeletal and Skin Diseases. http://niams.nih.gov

Natelson, B. H. (2001, May23/30). Contempo Updates: "Linking Evidence and Experience: Chronic Fatigue Syndrome". JAMA, 285(20).

Newton, J.L., Okonkwo, O., Sutcliffe, K., Seth, A., Shin, J., Jones, D.E. (2007, August). Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM.100(8), pp. 519-26.

Niddim, D.M., Chan, R.C., Lee, S.H., Yeh, T.C., Hsieh, J.C.. (2008 Feb 1) Central representation of hyperalgesia from myofascial trigger point. NeuroImage.,39, pp. 1299-1306.

Parker, A. J., Wessely, S., and Cleare, A. J. (2001, November). The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med., 31(8), pp. 1331-1345.

Rowe, P. C. (1998). Neurally Mediated Hypotension and CFS. 1998 Clinical and Scientific Meeting. http://www.ahmf.org/98rowe.html. Accessed. 12/28/01 and 8/7/03.

Simons, D. G. Update of Myofascial Pain from TrPs. From Medical Pain Education. www.pain-education.com http://websites.golden-orb.com/paineducation/100129.php

Starlanyl, D. & Copeland, M. E. (2001). Fibromyalgia and Chronic Myofascial Pain: A Survival Manual. Oakland, CA: New Harbinger Publications, Inc.

Starlanyl, D. & Copeland, M. E. (2001). Life Crises: Preparation, Prevention, and Management. Fibromyalgia and Chronic Myofascial Pain: A Survival Manual, pp. 153-157. Oakland, CA: New Harbinger Publications, Inc.

Starlanyl, D. and Copeland, M. E. (2001). Fibrofog and Other Cognitive Deficits. Fibromyalgia and Chronic Myofascial Pain: A Survival Manual. (pp. 199-207). Oakland, CA: New Harbinger Publications, Inc.

Staud, R., Robinson, M.E., Price DD. (2007, Nov). Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain. (11), pp. 893-901.

Suhadolnik, R. J., Peterson, D. L., Obrien, K. Cheney, P. R., Herst, C. V. T., Reichenbach, N. L., Kon N., Horvath, S. E., Iacono, K. T., Adelson, M. E., DeMeirleir, K., Debecker, P., Charubala, R., & Pfleiderer W. (1997, July). Biochemical evidence for a novel low molecular weight 2-5A-dependent RNaseL in chronic fatigue syndrome. Journal of Interferon and Cytokine Research, 17(7), 377-385.

Travell, J. G. and Simons, D. G. (1992). Myofascia lPain and Dysfunction: The Trigger Point Manual, Vol. II. Baltimore: Williams and Wilkins.

Walsh, R. (1999). The Seven Central Practices to Awaken Heart and Mind: Essential Spirituality: Exercises form the World's Religions to Cultivate Kindsness, Love, Joy, Peace, Vision, Wisdon, and Generosity. New York: John Wiley & Sons, Inc.